(Q40563380)

English

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.

scientific article published on July 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Martin R. Sprick

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Wolfgang Stremmel

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

T M Ganten

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

J Sykora

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

H Stahl

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

S C Fas

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

A Krueger

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

M A Weigand

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

A Grosse-Wilde

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

P H Krammer

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

H Walczak

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 July 2004

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Cell Death & Differentiation

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

11 Suppl 1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

S86-96

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4401437

0 references

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Is TRAIL hepatotoxic?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Characterization of two receptors for TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

CD95's deadly mission in the immune system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Apoptosis and drug response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

TRAIL and inhibitors of apoptosis are opposing determinants for NF-kappaB-dependent, genotoxin-induced apoptosis of cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Inhibition of death receptor signals by cellular FLIP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

The bile acid glycochenodeoxycholate induces trail-receptor 2/DR5 expression and apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Death and decoy receptors and p53-mediated apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

The short splice form of Casper/c-FLIP is a major cellular inhibitor of TRAIL-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

The role of c-FLIP in modulation of CD95-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Intracellular mechanisms of TRAIL and its role in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

21 January 2018

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

7 January 2021

based on heuristic

inferred from DOI database lookup

The death receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemistry and function of the DISC

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

7 January 2021

based on heuristic

inferred from DOI database lookup

Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

7 January 2021

based on heuristic

inferred from DOI database lookup

TNF-related apoptosis-inducing ligand-induced apoptosis of melanoma is associated with changes in mitochondrial membrane potential and perinuclear clustering of mitochondria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

7 January 2021

based on heuristic

inferred from DOI database lookup

Rel/NF-kappaB transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

7 January 2021

based on heuristic

inferred from DOI database lookup

On the TRAIL from p53 to apoptosis?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

7 January 2021

based on heuristic

inferred from DOI database lookup

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

7 January 2021

based on heuristic

inferred from DOI database lookup

TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401437

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CDD.4401437

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15105837%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40563380&oldid=2098611696"